hyoscyamine has been researched along with zileuton in 2 studies
Studies (hyoscyamine) | Trials (hyoscyamine) | Recent Studies (post-2010) (hyoscyamine) | Studies (zileuton) | Trials (zileuton) | Recent Studies (post-2010) (zileuton) |
---|---|---|---|---|---|
99 | 1 | 55 | 551 | 64 | 193 |
Protein | Taxonomy | hyoscyamine (IC50) | zileuton (IC50) |
---|---|---|---|
Prostaglandin E synthase | Homo sapiens (human) | 0.6 | |
Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 1.4782 | |
Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 0.9656 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | 0.4 | |
Arachidonate 5-lipoxygenase-activating protein | Homo sapiens (human) | 0.58 | |
Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | 0.591 | |
Polyunsaturated fatty acid 5-lipoxygenase | Mus musculus (house mouse) | 0.19 | |
Leukotriene B4 receptor 1 | Homo sapiens (human) | 0.42 | |
Cysteinyl leukotriene receptor 2 | Homo sapiens (human) | 0.42 | |
Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | 0.42 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
2 other study(ies) available for hyoscyamine and zileuton
Article | Year |
---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |